Is Stony Brook Urology University Faculty Practice Corporation Legit?

Stony Brook Urology University Faculty Practice Corporation demonstrates consistent financial activity, with revenues generally tracking expenses closely over the past decade. For instance, in 2023, revenue was $15,517,244 against expenses of $15,944,655, indicating a slight operational deficit. The organization's assets have shown growth over time, from $867,773 in 2014 to $2,886,442 in 2023, suggesting a stable, albeit not rapidly accumulating, financial position. A notable aspect is the consistent reporting of 0% officer compensation across all available filings, which is unusual for an organization of this size and could indicate that executive compensation is reported under different categories or is handled by an affiliated entity, warranting further investigation for complete transparency. Spending efficiency appears to be focused on core operations, given the close alignment of revenues and expenses. The NTEE code E20 (Hospitals) suggests a direct service delivery model, where most expenditures would naturally go towards program services. However, without a detailed breakdown of functional expenses (program, administrative, fundraising) in the provided data, a precise assessment of spending efficiency is challenging. The organization's liabilities consistently match its assets in each filing period, which is a peculiar accounting presentation that might indicate a specific fund accounting method or inter-entity transactions, rather than a true reflection of net assets. Transparency regarding executive compensation is a potential area for improvement, as the 0% reported officer compensation across all filings is atypical. While the organization consistently files its IRS Form 990, the lack of detailed functional expense breakdowns in the provided summary limits a full understanding of how funds are allocated between programs, administration, and fundraising. The consistent asset-liability matching also raises questions about the true financial structure and net asset position, which could benefit from clearer disclosure.